A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. LaingPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKAnna LorencPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKIrene del Molino del BarrioPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKAbhishek DasLondon School of Hygiene & Tropical Medicine, London, UKMatthew FishDepartment of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UKLeticia MoninThe Francis Crick Institute, London, UKMiguel Muñoz‐RuizThe Francis Crick Institute, London, UKDuncan R. McKenzieThe Francis Crick Institute, London, UKThomas S. HaydayPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKIsaac Francos-QuijornaRegeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UKShraddha KamdarPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKMagdalene JosephPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKDaniel DaviesDepartment of Plastic and Reconstructive Surgery, Royal Free NHS Foundation Trust, London, UKRichard DavisPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKA.R. JenningsDepartment of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UKIva ZlatarevaPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKPierre VantouroutPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKYin WuPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKVasiliki SofraPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKFlorencia CanoThe Francis Crick Institute, London, UKMaria GrecoThe Francis Crick Institute, London, UKEfstathios TheodoridisPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKJoshua D. FreedmanPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKSarah GeePeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UKJulie ChanComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKSarah RyanDepartment of Inflammation Biology, King's College London, London, UKEva Bugallo-BlancoComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKPärt PetersonMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, EstoniaKai KisandMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, EstoniaLiis HaljasmägiMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, EstoniaLoubna ChadliCenter for Therapeutic Innovation in Immuno-inflammation, Servier, FrancePhilippe MoingeonCenter for Therapeutic Innovation in Immuno-inflammation, Servier, FranceLauren MartinezInfectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UKBlair MerrickCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UKKaren BisnauthsingCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UKKate BrooksInfectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UKMohammad A. A. IbrahimImmunological Medicine, Kings College Hospital NHS Foundation Trust, London, UKJeremy MasonThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UKFederico LópezThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UKKola BabalolaThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UKSultan Abdul-JawadComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKJohn CasonDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UKChristine MantDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UKJeffrey SeowDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UKCarl GrahamDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UKKatie J. DooresDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UKFrancesca Di RosaInstitute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, ItalyJonathan D. EdgeworthCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UKManu Shankar‐HariDepartment of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK. [email protected]Adrian HaydayPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. [email protected]
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0